山东新华制药股份（00719）8月11日公告称，公司董事会将于2026年8月25日（星期二）上午9时30分，在中国山东省淄博市高新区鲁泰大道1号公司会议室召开董事会会议。会议拟审议及批准公司及其附属公司截至2026年6月30日止六个月的未经审计中期业绩，并处理其他适用事宜。
公告同时列明，公司董事会目前由三位执行董事、四位独立非执行董事及一位非执行董事组成，分别为：
1. 执行董事：贺同庆（董事长）、徐文辉、侯宁 2. 独立非执行董事：潘广成、朱建伟、凌沛学、张菁菁 3. 非执行董事：张成勇
本次会议有关决议结果将另行公布。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.